GI INNOVATION, INC.
9Patents
9Active
9Granted
47Portfolio score
Filing activity: Jan 8, 2019 → Aug 26, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12128076B2 | Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11639383B2 | Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain | Emerging Cross-Sectional Technologies | 1 | Active |
| US11492384B2 | Fusion protein comprising IL-2 protein and CD80 protein, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11857601B2 | Pharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drug | Chemistry; Metallurgy | 1 | Active |
| US12410233B2 | Extracellular domain of alpha subunit of IgE Fc receptor, pharmaceutical composition comprising same and method for producing same | Chemistry; Metallurgy | 0 | Active |
| US12286464B2 | Fusion protein comprising IL-2 protein and CD80 protein, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12291555B2 | Fusion protein comprising IL-2 protein and CD80 protein, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12409203B2 | Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of IGE FC receptor, and pharmaceutical composition comprising same | Chemistry; Metallurgy | 0 | Active |
| US12414984B2 | Fusion protein comprising anti-CD73 antibody and IL-2, and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.